Exploring how different RA treatments affect cholesterol profiles and cardiovascular risk in rheumatoid arthritis patients.
Exploring the effectiveness of switching between IL-6 receptor inhibitors and JAK inhibitors in rheumatoid arthritis treatment based on real-world data from the CorEvitas registry.